Co
Non verificato

Corsair Pharma, Inc.

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute
08/06/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Cardiologia
Corsair Pharma Announces Three Presentations of Phase 1 Clinical Data for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference
1.00
01/06/2026
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Industria
Corsair Pharma Announces Positive Phase 1 Results for the TRX-248 Transdermal System in Pulmonary Arterial Hypertension
1.00
15/09/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Cardiologia
Eventi
Fiere
Industria
Corsair Pharma to Present New Data on Proprietary Treprostinil Prodrug Transdermal System at PHPN 2025 Symposium
1.00
17/03/2025
Industria
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0